Patterson Companies Completes Acquisition by Patient Square Capital
In conjunction with the closing of the acquisition, Patterson is pleased to announce the appointment of Robert Rajalingam as the new Chief Executive Officer of Patterson. Don Zurbay, who previously served as CEO, will be retiring and will continue to support the Company on a transitional basis. Mr. Rajalingam has more than 25 years of experience in health care management, most recently as President of Cardinal Health's US Medical Products and Distribution business, where he led a significant transformation in the business. Mr. Rajalingam has also held leadership roles at Smiths Medical, Medtronic, Covidien, and Lilly.
Speaking on his new role, Mr. Rajalingam said, 'I am honored to join Patterson Companies at this pivotal time. The company has a strong foundation and an unwavering commitment to serving its dental and animal health customers. I look forward to working closely with the Patient Square team and the talented employees of Patterson to enhance our offerings, strengthen our partnerships, and deliver exceptional value to our customers.'
Don Zurbay, prior CEO of Patterson, said, 'I am proud of the Patterson team and everything that we have accomplished over the last several years and believe that this transaction and Robert's leadership will help drive the business to new heights.'
Justin Sabet-Peyman, Partner at Patient Square and Director of Patterson, said, 'With the completion of this acquisition, we are confident that Patterson is well-positioned to live up to its potential while building on its proud legacy. Robert brings a wealth of relevant experience and a proven track record of driving operational excellence and strategic growth. We are also very grateful to Don for his years of service to the Company."
Patterson Companies will maintain its headquarters in St. Paul, Minnesota.
About Robert Rajalingam
Prior to joining Patterson Companies, Mr. Rajalingam was a member of Cardinal Health's Operating Committee, where he led the resurgence of the US Medical Products and Distribution business while successfully navigating national COVID response efforts, a significant FDA recall, global supply chain constraints, and hyperinflation. From the onset of the pandemic, he served on the White House Supply Chain advisory council, advising HHS, FEMA, DLA, and White House senior leadership. Prior to Cardinal Health, Robert held leadership positions at Medtronic, Covidien, and Smiths Medical, exceeding performance targets and driving shareholder value. Robert holds bachelor's degrees in biomedical engineering and economics from Duke University and a Master of Business Administration from Stanford University's Graduate School of Business.
About Patterson Companies Inc.
Patterson Companies Inc. connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support. Learn more: www.pattersoncompanies.com, www.animalhealthinternational.com
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm with approximately $12 billion in assets under management as of December 31, 2024. The firm aims to achieve strong investment returns by partnering with growth-oriented companies and top-tier management teams whose products, services, and technologies improve health. Patient Square utilizes deep industry expertise, a broad network of relationships, and a partnership approach to make investments in companies that will grow and thrive. Patient Square invests in businesses that strive to improve patient lives, strengthen communities, and create a healthier world. For more information, visit www.patientsquarecapital.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
RFK Indefinitely Postponed A Critical Meeting — And It Could Have 'Devastating Effects' On All Of Us
It's hard to keep track of the funding cuts, layoffs, vaccine recommendation changes and other major shake-ups happening within the country's federal public health organizations at the hands of the Trump administration and Robert F. Kennedy Jr., the health and human services secretary. One of the latest changes is RFK Jr's postponement of a preventive health panel meeting by the United States Preventive Services Task Force (USPSTF), which was scheduled for July 10 and the rumored dismissal of all task force members, as reported by the Wall Street Journal. The USPSTF sets guidelines for preventive health screenings for conditions such as diabetes, depression and cancer in children and adults. Insurance companies are then required to cover these screenings based on the USPSTF's guidelines. This news comes not long after Kennedy postponed the meeting of the Advisory Committee on Immunization Practices (ACIP), which sets vaccine recommendations, and replaced the entire committee with individuals known to spread vaccine and health misinformation, according to earlier HuffPost reporting. The changes to the USPSTF meeting and task force members is worrisome for a few reasons and could directly impact your health. Here's what doctors want you to know: This task force sets preventive screening recommendations. Changes or delays to the meeting schedule can mean missed diagnoses or changes to what insurance companies cover. The United States Preventive Services Task Force, which was formed in 1984, is a group of non-partisan volunteers who are 'nationally recognized experts' in the fields of primary care, prevention and evidence-based medicine, according to the USPTF website. All members are screened for biases, are chosen through public nomination and appointed by the Health and Human Services secretary. They serve four-year terms with new task force members rotating in each year. 'The cancellation of this specific task force ... is going to affect every American if [Kennedy and the U.S. Department of Health and Human Services does] what they did to the ACIP and fire or remove the 16 independent medical experts who really scour the literature and then grade the evidence for each of their recommendations,' Dr. Anita Patel, a pediatric critical care doctor in Washington, D.C., told HuffPost. Once again, this hasn't been done yet, but it is allegedly in the works. One of the significant roles of the task force is to make recommendations and guidelines for preventative care services such as mammograms, colonoscopies, depression screenings and more, said Patel. Insurance companies are then required to cover these screenings and services as part of the Affordable Care Act. Doctors across the country also follow these guidelines when recommending health services for patients. In response to the reports of the dismissal of current task force members, the American Medical Association sent a letter to RFK Jr. in support of the task force in which they said, 'USPSTF plays a critical, non-partisan role in guiding physicians' efforts to prevent disease and improve the health of patients by helping to ensure access to evidence-based clinical preventive services.' Sen. Elizabeth Warren (D-Mass.) and Sen. Angus King (I-Maine) also backed the task force by introducing a resolution that underscores the importance of the group, according to NPR. 'If the [task force] is unable to continue its work, this could have devastating effects on access to preventive services,' Dr. Oni Blackstock, a primary care physician and executive director of Health Justice, a racial and health equity consultancy, told HuffPost via email. 'We [already] know millions of Americans are at risk for losing their Medicaid,' Blackstock said, referring to the nearly $1 trillion cuts in Medicaid as part of the so-called Big, Beautiful Bill. 'Now, many others who have insurance coverage will be at risk for losing no-cost coverage of preventive care services,' added Blackstock. It's worth knowing that the meeting is currently postponed; it's not clear when it will happen instead, and who will be part of the task force when that time comes. But, as of now, what the task force recommends hasn't changed. 'Canceling the USPSTF meeting without a clear plan to reschedule puts essential, evidence-based health guidance at risk, including continued access to preventive services that millions of Americans rely on, from cancer and diabetes screenings to depression checks to support for breastfeeding,' Dr. David Higgins, a pediatrician and preventive medicine specialist at the University of Colorado Anschutz Medical Campus, told HuffPost via email. Any delays to the task force's meeting schedule can also cause issues. 'Delays or disruptions can mean delayed diagnoses, missed opportunities for early treatment, and ultimately, worse health outcomes,' added Higgins. Not only do these changes threaten the guidance from the task force, but they 'affect whether a patient catches their cancer early enough or a person with chronic heart disease gets optimal treatment,' he noted. The task force was recently criticized for being 'woke,' which some experts think is why it's being targeted now. 'Unfortunately, this [postponement] fits a troubling pattern of political interference in scientific and public health processes,' Higgins said. Just a few days after Kennedy told panel members that the preventive health meeting was postponed, 'The American Conservative' published an essay titled 'Time for Kennedy to Kill the USPSTF.' The article claimed the task force is 'woke' and follows 'left-wing ideological orthodoxy' and is part of the 'deep state,' among other things. 'The claim that the task force is driven by 'woke' ideology is a political talking point, not a reflection of how the USPSTF actually operates,' said Higgins. 'Their work is based on a rigorous review of scientific evidence. Identifying and addressing disparities in health outcomes is part of delivering high-quality care,' Higgins added. It's well-established that certain demographics do have worse health care outcomes; Black people have higher rates of maternal mortality than other groups, upward of 50% of Latinx folks are predicted to be diagnosed with diabetes, Black people are 30% more likely to have asthma than white people and the list goes on. The task force should be considering how race and gender impacts health outcomes. Blackstock noted that USPSTF hasn't always done this, but that is changing. 'It's lacked community voices and, for a long time, didn't focus on health equity or racism's impact on health and was not focused on ensuring diverse representation among its members,' Blackstock said. Recently, though, this has changed, and the task force has worked to address these issues, Blackstock added. 'It has taken steps to formalize the use of inclusive language, and to flag if data is missing for a population, particularly those that are minoritized,' Blackstock said. The group is also piloting an equity checklist that helps integrate equity throughout the screening recommendation process, Blackstock noted. These recent steps put a target on USPSTF's back, she said. 'I believe this is why the [task force] is being targeted, because it is paying attention to health inequities and racism's harmful effects on health,' Blackstock said. Patel added that USPSTF isn't taking care away from white Americans. Instead, it's 'trying to level the playing field so that everyone got equal care,' Patel noted. 'But, of course, [critics of the task force] saw the term 'diversity' or 'equity' and really tried to blow up one part of a much larger organization to play to their base and say, 'Hey, these guys are woke idiots,'' Patel said. USPSTF is now trying to advance medicine and make sure everyone, no matter where they live or what they look like, has access to preventive health screenings. The task force is here to 'take out the inherent racism that we've had in medicine for decades that has been really unduly perpetuated,' Patel noted. While racism does certainly still exist in medicine, awareness allows medical professionals to address any biases and make sure everyone gets the care they deserve regardless of their race, socioeconomic background or ethnicity, Patel noted. 'It's an evil thing to walk back all of these medical and diversity advancements that we've made in the past decade just because they want to pander to their base. It's unconscionable,' Patel said. Related... Experts Say Trump's Big Bill Will Shut Down This 1 Type Of Hospital — And It'll Impact Multitudes COVID Cases Are Rising This Summer, But Not All The Data Shows It — Here's Why RFK Jr. Keeps Telling A Flat-Out Lie About Childhood Vaccines — And Doctors Are Sick Of It Solve the daily Crossword
Associated Press
2 days ago
- Associated Press
Opendoor Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. ('Opendoor' or the 'Company') (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today announced it received written notice from the Nasdaq Stock Market LLC that the Company has regained compliance with Nasdaq's minimum bid price requirement. Opendoor's common stock will continue to be listed on the Nasdaq Global Select Market. To regain compliance with the minimum bid price requirement, the Company's shares were required to maintain a closing bid price of $1.00 or more for at least 10 consecutive business days. Nasdaq's notice confirmed that Opendoor maintained a closing bid price of at least $1.00 for 12 consecutive business days from July 15, 2025 to July 30, 2025, thereby regaining compliance with the minimum bid price requirement. Accordingly, Nasdaq has determined that the matter is now closed. The Board of Directors of the Company has decided to cancel the Special Meeting of Stockholders, scheduled for August 27, 2025, which was intended to consider two proposals related to a discretionary reverse stock split of the Company's common stock. In light of Opendoor regaining compliance with the minimum bid price requirement, the Board has determined that it is in the best interests of the Company and its stockholders to not proceed with the reverse stock split proposal at this time and to cancel the Special Meeting. About Opendoor Opendoor is a leading e-commerce platform for residential real estate transactions whose mission is to power life's progress, one move at a time. Since 2014, Opendoor has provided people across the U.S. with a simple and certain way to sell and buy a home. Opendoor is a team of problem solvers, innovators, and operators who are leading the future of real estate. Opendoor currently operates in markets nationwide. For more information, please visit Forward Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding the Company's ability to comply with the continued listing requirements for the Nasdaq Global Select Market. These forward-looking statements generally are identified by the words 'anticipate', 'believe', 'contemplate', 'continue', 'could', 'estimate', 'expect', 'forecast', 'future', 'guidance', 'intend', 'may', 'might', 'opportunity', 'outlook', 'plan', 'possible', 'potential', 'predict', 'project', 'should', 'strategy', 'strive', 'target', 'vision', 'will', or 'would', any negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. The factors that could cause or contribute to actual future events to differ materially from the forward-looking statements in this press release include but are not limited to: the Company's ability to continue to comply with the continued listing requirements of the Nasdaq Global Select Market; risks associated with the Company's indebtedness and capital structure; the current and future health and stability of the economy, financial conditions and residential housing market, including any extended downturns or slowdowns; changes in general economic and financial conditions (including federal monetary policy, the imposition of tariffs and price or exchange controls, interest rates, inflation, actual or anticipated recession, home price fluctuations, and housing inventory), as well as the probability of such changes occurring, that impact demand for the Company's products and services, lower the Company's profitability or reduce its access to future financings; actual or anticipated fluctuations in the Company's financial condition and results of operations; the Company's ability to access sources of capital, including debt financing and securitization funding to finance its real estate inventories and other sources of capital to finance operations and growth; and the volatility in the price of the Company's common stock. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described under the caption 'Risk Factors' in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the 'SEC') on February 27, 2025, as updated by its periodic reports and other filings with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. The Company does not give any assurance that it will achieve its expectations. Contacts Investors: [email protected] Media: [email protected]
Business Wire
2 days ago
- Business Wire
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: To register for the conference call, please use this link: To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. To access the webcast: Participants will receive their details via email. A replay of the webcast will be available within 24 hours after the conclusion of the call at and will be archived for a period of 90 days following the call. About Organigram Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. Organigram Global is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram Global has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, DEBUNK and Collective Project. Organigram Global operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Forward-Looking Information This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information including expectations regarding market performance, involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
